Ankur Drugs & Pharma Ltd
Ankur Drugs & Pharma Limited, incorporated in India, Listed on the Bombay Stock exchange Limited, and National Stock Exchange Limited, the company is engaged in Pharmaceutical Formulations
- Market Cap ₹ Cr.
- Current Price ₹ 3.93
- High / Low ₹ /
- Stock P/E
- Book Value ₹ 123
- Dividend Yield 0.00 %
- ROCE -6.75 %
- ROE -65.0 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Stock is trading at 0.03 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -16.5% over past five years.
- Company has a low return on equity of -17.1% over last 3 years.
- Company might be capitalizing the interest cost
- Debtor days have increased from 37.4 to 76.5 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| 135 | 373 | 674 | 965 | 1,067 | 825 | 151 | |
| 113 | 315 | 567 | 833 | 860 | 690 | 176 | |
| Operating Profit | 22 | 58 | 107 | 132 | 207 | 135 | -25 |
| OPM % | 16% | 16% | 16% | 14% | 19% | 16% | -16% |
| 0 | 0 | 2 | 2 | 20 | -0 | -144 | |
| Interest | 4 | 13 | 25 | 54 | 81 | 121 | 58 |
| Depreciation | 2 | 6 | 8 | 21 | 27 | 61 | 61 |
| Profit before tax | 15 | 39 | 75 | 59 | 120 | -47 | -288 |
| Tax % | 9% | 17% | 15% | 37% | 28% | 47% | 7% |
| 14 | 33 | 64 | 37 | 86 | -69 | -307 | |
| EPS in Rs | 31.01 | 50.00 | 19.95 | 44.56 | -35.58 | -158.98 | |
| Dividend Payout % | 10% | 6% | 4% | 11% | 5% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -17% |
| 3 Years: | -46% |
| TTM: | -82% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -151% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -4% |
| 3 Years: | -17% |
| Last Year: | -65% |
Balance Sheet
Figures in Rs. Crores
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 11 | 13 | 19 | 19 | 19 | 19 |
| Reserves | 19 | 103 | 207 | 253 | 338 | 269 | 219 |
| 111 | 352 | 618 | 745 | 950 | 1,157 | 857 | |
| 16 | 40 | 62 | 118 | 566 | 334 | 434 | |
| Total Liabilities | 156 | 505 | 900 | 1,135 | 1,873 | 1,779 | 1,529 |
| 33 | 112 | 204 | 346 | 704 | 1,220 | 1,159 | |
| CWIP | 66 | 245 | 331 | 266 | 786 | 285 | 266 |
| Investments | 0 | 0 | 5 | 4 | 0 | 0 | 0 |
| 58 | 148 | 359 | 519 | 383 | 275 | 103 | |
| Total Assets | 156 | 505 | 900 | 1,135 | 1,873 | 1,779 | 1,529 |
Cash Flows
Figures in Rs. Crores
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| 8 | 23 | 22 | 42 | 844 | -41 | 3 | |
| -59 | -188 | -191 | -94 | -938 | -92 | 24 | |
| 53 | 165 | 226 | 9 | 88 | 130 | -27 | |
| Net Cash Flow | 1 | 0 | 56 | -43 | -6 | -2 | 0 |
Ratios
Figures in Rs. Crores
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 76 | 75 | 89 | 106 | 19 | 17 | 77 |
| Inventory Days | 86 | 77 | 83 | 105 | 120 | 98 | 57 |
| Days Payable | 19 | 31 | 24 | 28 | 207 | 85 | 478 |
| Cash Conversion Cycle | 144 | 121 | 148 | 183 | -68 | 29 | -344 |
| Working Capital Days | 119 | 109 | 134 | 154 | -67 | -14 | -722 |
| ROCE % | 17% | 15% | 12% | 17% | 5% | -7% |